Solid Tumor Metastatic Cancer Advanced Cancer
2 clinical trials · Condition
◉ Watch Solid Tumor Metastatic Cancer Advanced Cancer
| Record | Firm | Date |
|---|---|---|
| Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001 (NCT05511350) | I-Mab Biopharma US Limited |
Track Solid Tumor Metastatic Cancer Advanced Cancer automatically
Every clearance here is in the API, with alerts when new ones post.